8.2 Naloxone, Syringes & Standing Orders

Over-the-Counter Harm Reduction & Standing Orders in Massachusetts

Massachusetts has enacted progressive harm reduction legislation to combat the opioid crisis, reduce bloodborne pathogen transmission, and improve public health access to critical preventive therapies. Pharmacists in the Commonwealth play a direct clinical role by dispensing naloxone, emergency contraception, hypodermic needles, and nicotine replacement therapy through statewide standing orders and OTC frameworks without individual patient-specific prescriptions.

Naloxone Standing Orders (M.G.L. c. 94C, § 19B)

To expand access to life-saving opioid reversal agents, Massachusetts passed legislation authorizing the Naloxone Statewide Standing Order under MGL c. 94C § 19B and DPH regulations (105 CMR 700.003).

Pharmacist Dispensing Authority

Under the statewide standing order issued by the DPH Medical Director, any licensed pharmacist in Massachusetts is legally authorized to dispense naloxone (nasal spray such as Narcan 4 mg or Kloxxado 8 mg, or intramuscular injectable formulations) to any individual requesting it.

• Target Recipients: Naloxone may be dispensed directly to a person at risk of an opioid overdose, or to a family member, friend, bystander, community organizer, or first responder who is in a position to assist an individual experiencing an overdose.
• No Individual Prescription Required: The standing order acts as a valid prescription for any patient presenting to the pharmacy.

Pharmacy Registration and Reporting

To participate under the Statewide Standing Order, retail pharmacies must:

1. File a standing order registration form with the DPH Drug Control Program.
2. Maintain a copy of the current DPH Statewide Standing Order on file at the pharmacy.
3. Submit annual aggregate dispensing reports to the DPH detailing the total number of naloxone doses dispensed under the standing order.

Labeling, Counseling, and Billing Protocols

• Labeling Requirements: The pharmacist must generate a standard prescription label affixed to the naloxone package. The label must list the name of the purchasing individual (or "Statewide Standing Order" if requested anonymously where permitted), the dispensing pharmacy's details, the standing order physician as the prescriber, and directions for use ("Use as directed in case of suspected opioid overdose").
• Mandatory Counseling: The pharmacist must offer verbal counseling and written educational materials to the purchaser. Counseling must cover:
  • Recognizing signs of an opioid overdose (unresponsiveness, pinpoint pupils, respiratory depression/cyanosis).
  • Step-by-step administration of nasal spray or injectable naloxone.
  • Mandatory instruction to call 911 immediately after administering naloxone, emphasizing that naloxone is temporary (lasts 30–90 minutes) and opioids may cause recurrent overdose as naloxone wears off.
  • Rescue breathing and post-administration positioning (recovery position).
• Insurance Billing: Pharmacists must bill the recipient's health insurance (including MassHealth, Medicare Part D, and commercial plans). Under Massachusetts law, commercial insurers and MassHealth are required to cover standing-order naloxone with minimal or no copayments.
• Immunity Protections: MGL c. 94C § 19B grants statutory civil and criminal liability protection (Good Samaritan immunity) to pharmacists who dispense naloxone in good faith pursuant to the standing order.

Emergency Contraception

Levonorgestrel 1.5 mg (Plan B One-Step and generics) is an FDA-approved over-the-counter product with no federal age restriction, and it may be sold from the shelf like any other non-prescription medicine. Ulipristal acetate 30 mg remains a prescription product.

Where a patient wishes to use insurance coverage for an over-the-counter product, a pharmacy may be able to process the claim under a standing order or protocol arrangement. Because the arrangements, the participating payers and the pharmacist-prescribing authority in this area have changed repeatedly, verify the current Massachusetts standing order, protocol or pharmacist-prescribing provision before billing emergency contraception as a prescription claim rather than assuming a fixed rule.

Counselling points are stable: levonorgestrel is most effective the sooner it is taken and is indicated within 72 hours of unprotected intercourse; ulipristal may be used up to 120 hours; emergency contraception does not terminate an established pregnancy; and temporary cycle changes and nausea are common.

OTC Hypodermic Needle and Syringe Sales (MGL c. 94C § 27)

Historically, Massachusetts heavily restricted hypodermic needles, requiring a physician prescription or proof of medical need. To combat the transmission of HIV, Hepatitis C, and bloodborne infections among people who inject drugs, the Massachusetts Legislature amended MGL c. 94C § 27.

Current Legal Requirements for Syringe Sales

• OTC Availability: Licensed pharmacists are legally authorized to sell hypodermic syringes and needles over-the-counter to any customer without a prescription.
• No Age Limits: There is no minimum age requirement to purchase hypodermic needles or syringes in Massachusetts.
• No Quantity Limits: There are no statutory caps on the number of needles or syringes a customer may purchase.
• No Logbook or Registration: Pharmacies are prohibited from maintaining a registry, logbook, or collecting personal identification from individuals purchasing hypodermic needles.
• Sharps Disposal Requirement: Pharmacists selling OTC syringes MUST provide educational materials regarding safe sharps disposal at the time of sale. Pharmacies are encouraged to participate in local sharps collection kiosk programs or offer puncture-resistant sharps disposal containers.

Statewide Standing Orders Generally

Massachusetts uses the statewide standing order as a general public-health tool, and M.G.L. c. 94C, § 19E is its clearest statutory expression: it authorises the Commissioner or an actively practising physician to issue a statewide standing order for licensed pharmacists to dispense COVID-19 control measures, and it protects both the issuing physician and the good-faith dispensing pharmacist from criminal, civil and professional liability except for gross negligence or wilful misconduct.

Other standing orders and collaborative arrangements — for nicotine replacement therapy, for contraception, for immunizations — are issued and revised by DPH and the Board over time. The durable exam point is the structure: a standing order operates as a valid prescription for a defined population, the dispensing pharmacist labels and counsels exactly as for any prescription, and good-faith dispensing under a lawful standing order carries statutory liability protection. The specific list of products covered at any moment must be read from the current standing orders published by DPH and the Board, not assumed.